ABUS
Arbutus Biopharma Corp
$4.87
+0.14 (+2.96%)
At close · Jul 2
Market Cap
$962.01M
Shares
197,537,710
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-05-27 | 2026-05-26 | |
| 8-K | 2026-05-13 | — | |
| 10-Q | 2026-05-13 | 2026-03-31 | |
| 8-K | 2026-04-15 | 2026-04-14 | |
| DEF 14A | 2026-04-14 | 2026-05-26 | |
| 10-K | 2026-03-23 | 2025-12-31 | |
| 8-K | 2026-03-23 | — | |
| 8-K | 2026-03-03 | — | |
| 8-K | 2026-02-20 | 2026-02-17 | |
| 8-K | 2026-02-06 | 2026-02-02 | |
| 8-K | 2026-01-16 | 2026-01-15 | |
| 8-K | 2025-12-11 | — | |
| 8-K | 2025-11-13 | — | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-10-07 | — | |
| 8-K | 2025-09-10 | 2025-09-09 | |
| 8-K | 2025-08-06 | 2025-08-04 | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-06-25 | 2025-06-20 | |
| 8-K | 2025-05-23 | 2025-05-21 | |
| 8-K | 2025-05-14 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-05-07 | — | |
| 8-K | 2025-04-23 | — | |
| DEF 14A | 2025-04-04 | 2025-05-21 | |
| 8-K | 2025-04-03 | 2025-03-28 | |
| 8-K | 2025-03-27 | — | |
| 10-K | 2025-03-27 | 2024-12-31 | |
| 8-K | 2025-03-03 | — | |
| 8-K | 2025-02-25 | 2025-02-24 | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-11-15 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-11-06 | — | |
| 8-K | 2024-10-15 | — | |
| 8-K | 2024-10-11 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-05 | — | |
| 8-K | 2024-08-01 | — | |
| 8-K | 2024-06-06 | — | |
| 8-K | 2024-06-05 | — | |
| 8-K | 2024-05-28 | 2024-05-22 | |
| 8-K | 2024-05-22 | — | |
| 8-K | 2024-05-02 | 2024-05-01 | |
| 8-K | 2024-05-02 | — | |
| 10-Q | 2024-05-02 | 2024-03-31 | |
| DEF 14A | 2024-04-10 | 2024-05-22 | |
| 8-K | 2024-04-04 | — | |
| 10-K | 2024-03-05 | 2023-12-31 | |
| 8-K | 2024-02-29 | — |
Showing 1–50 of 157 filings